Department of Epidemiology, School of Public Health, Sun Yat-sen University, Guangzhou, 510080, People's Republic of China.
Guangdong Provincial Key Laboratory of Food, Nutrition and Health, School of Public Health, Sun Yat-sen University, Guangzhou, 510080, People's Republic of China.
Endocr J. 2020 Mar 28;67(3):257-266. doi: 10.1507/endocrj.EJ19-0319. Epub 2019 Nov 19.
Little is known about the association between equol and bioavailable testosterone (BT) in adults. In this study, we examined the associations of urinary equol concentrations with serum concentrations of total, bioavailable and free testosterone (FT), dehydroepiandrosterone sulfide (DHEAS), free androgen index (FAI) and sex hormone-binding globulin (SHBG). This cross-sectional study included 1,904 women with a mean age of 59.7 years. Urinary equol concentrations were measured using high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS). The serum androgenic indices and SHBG were also determined. Overall, urinary equol tended to be inversely associated with bioactive forms of androgenic indices (BT, FT or FAI) but not with total testosterone (TT) or DHEAS. Urinary equol was also positively associated with SHBG. In multi-covariate-adjusted analyses stratified by menopausal status, graded and inverse associations between urinary equol and bioactive forms of androgenic indices (BT, FT and FAI) were observed in postmenopausal women (all p-trends < 0.05), but not in premenopausal women. A significant positive association between urinary equol and SHBG was observed only in postmenopausal women. No significant associations were observed between urinary equol and TT or DHEAS in either group. A path analysis indicated that these associations of equol with androgens in postmenopausal women might be mediated by SHBG. In conclusion, urinary equol exhibited graded and inverse associations with BT or FT, but not TT in women. However, further longitudinal studies of human patients are needed to confirm these results and overcome the limitations of cross-sectional studies.
关于成年人中结合型雌马酚与生物可利用睾酮(BT)之间的关系知之甚少。在这项研究中,我们研究了尿中结合型雌马酚浓度与血清总睾酮(TT)、生物可利用睾酮(BT)、游离睾酮(FT)、脱氢表雄酮硫酸酯(DHEAS)、游离雄激素指数(FAI)和性激素结合球蛋白(SHBG)浓度之间的关联。该横断面研究共纳入了 1904 名年龄平均为 59.7 岁的女性。使用高效液相色谱-串联质谱法(HPLC-MS/MS)测定尿中结合型雌马酚浓度。还测定了血清雄激素指标和 SHBG。总体而言,尿中结合型雌马酚与生物活性形式的雄激素指标(BT、FT 或 FAI)呈负相关,但与 TT 或 DHEAS 无关。尿中结合型雌马酚与 SHBG 呈正相关。在按绝经状态分层的多变量调整分析中,绝经后女性的尿结合型雌马酚与生物活性形式的雄激素指标(BT、FT 和 FAI)呈分级和负相关(所有 p 趋势<0.05),而在绝经前女性中则无相关性。仅在绝经后女性中观察到尿结合型雌马酚与 SHBG 之间存在显著的正相关。在两组中均未观察到尿结合型雌马酚与 TT 或 DHEAS 之间存在显著相关性。路径分析表明,绝经后女性中结合型雌马酚与雄激素之间的这些关联可能是由 SHBG 介导的。总之,尿结合型雌马酚与 BT 或 FT 呈分级和负相关,但与 TT 无关。然而,需要进一步对人类患者进行纵向研究来证实这些结果并克服横断面研究的局限性。